Nordea Investment Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.4M Buy
229,027
+1,446
+0.6% +$60.6K 0.01% 413
2026
Q1
$7.13M Sell
227,581
-10,134
-4% -$375K 0.01% 516
2025
Q4
$10.1M Sell
237,715
-34,882
-13% -$1.41M 0.01% 441
2025
Q3
$9.16M Buy
272,597
+6,523
+2% +$187K 0.01% 467
2025
Q2
$7.32M Buy
266,074
+3,162
+1% +$91.6K 0.01% 482
2025
Q1
$7.74M Buy
262,912
+1,698
+0.7% +$64.7K 0.01% 452
2024
Q4
$10.4M Buy
261,214
+11,078
+4% +$419K 0.01% 398
2024
Q3
$8.38M Sell
250,136
-12,732
-5% -$358K 0.01% 440
2024
Q2
$5.64M Sell
262,868
-9,308
-3% -$196K 0.01% 507
2024
Q1
$6.05M Buy
272,176
+190,262
+232% +$4.64M 0.01% 507
2023
Q4
$2.28M Sell
81,914
-754
-0.9% -$18.2K ﹤0.01% 686
2023
Q3
$1.87M Buy
+82,668
New +$2.13M ﹤0.01% 703

Other funds holding VCYT

Nordea Investment Management's VCYT Position: Q2 2026 in Review

Nordea Investment Management increased its Veracyte (VCYT) stake by 0.64% in Q2 2026, buying an estimated $60.6K and bringing the position to 229,027 shares worth $13.4M. The position accounts for 0.01% of the portfolio, ranked #413.

Nordea Investment Management first reported a position in VCYT in Q3 2023 and has held it in 12 quarters since. 125 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Nordea Investment Management held 229,027 shares of Veracyte worth $13.4M as of Q2 2026.
  • Nordea Investment Management bought 1,446 Veracyte shares in Q2 2026, an estimated $60.6K.
  • Veracyte made up 0.01% of Nordea Investment Management's portfolio in Q2 2026, its #413 holding.
  • Nordea Investment Management first reported a position in Veracyte in Q3 2023 and has held it in 12 quarters since.
  • 125 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.